MEBO Group Leads Regenerative Innovation at the 7th China International Import Expo
From November 5-10, 2024, MEBO Group took center stage at the 7th China International Import Expo (CIIE), marking its seventh consecutive year of participation. Focused on the theme "Regenerative World, Healthy Future," MEBO showcased premium regenerative products, emphasizing its commitment to innovation and excellence in the regenerative medicine and healthcare sectors.
MEBOGO Platform: Empowering Global Trade and Innovation
A major attraction was the MEBO International Trade and Service Sharing Platform, featuring over 100 products in an engaging and interactive display. MEBOGO has established itself as a key bridge for global trade, linking businesses through streamlined cooperation, resource integration, and collaborative opportunities. This platform enriches MEBO’s offerings, showcasing its strategic foresight and growth.
Strengthening APEC Partnerships and Humanitarian Commitment
As a strategic APEC partner in 2023 and 2024, MEBO underscored its commitment to international cooperation. Through its 2024 Life Regeneration Action, MEBO demonstrated its dedication to humanitarian aid, particularly in women’s and children’s healthcare.
Collaborations and Cultural Milestones with PAPER Magazine
MEBO also partnered with the Bay Area Council Economic Institute to release the "California Model and Global Insights" white paper. In celebration of the 40th anniversary of PAPER magazine, MEBO launched a Spanish edition at CIIE and a special APEC event in Peru, broadening its cultural influence.
Cross-Industry Collaboration with the NBA’s Sacramento Kings
In a unique partnership, MEBO joined forces with the NBA’s Sacramento Kings, while its red panda mascot “Little MEBO” from the San Francisco Zoo captivated CIIE attendees, symbolizing MEBO’s commitment to life and innovation.
MEBO’s seventh year at CIIE showcased its dynamic ecosystem and dedication to global trade and healthcare, reaffirming its role as a leader in regenerative health and international cooperation.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.